 |
Deposito minimo $50 Promozione esclusiva |
Il nostro punteggio |
0% commissione |
Are you looking to buy DexCom stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:DXCM! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about DexCom stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient’s mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products; a collaboration with Companion Medical, Inc.; and a development and commercialization agreement with Tandem Diabetes Care, Inc. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Volume medio
943,679 shs
TAPPA DEL MERCATO
$39.22 billion
Borsa valori
NASDAQ
Compri queste azioni!
|
NOME
|
TICKER
|
INDUSTRIA
|
SETTORE
|
VOLUME
|
COMPRI ORA QUESTE AZIONI
|
|---|---|---|---|---|---|
|
NASDAQ:DXCM
|
Strumenti chirurgici e medici
|
Medico
|
6,266 shs
|
Below is a quick guide on how to buy NASDAQ:DXCM stocks safe, fast and around the world in less than five minutes.
Passo 1: Aprire un conto con eToro – eToro is the best broker to buy DexCom shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: caricare il suo ID - Come da regolamento KYC eToro le chiederà di caricare una copia del suo passaporto o della sua patente di guida.
Passo 3: Deposito di fondi - Depositi del denaro nel suo conto eToro appena creato. Può scegliere tra bonifico bancario, e-wallet o carta di debito/credito o Paypal.
Passo 4: Buy DexCom – Search for “”NASDAQ:DXCM”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought DexCom stocks with 0% commission!.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
18 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for DexCom in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” DexCom stock.
Wall Street analysts have given DexCom a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but DexCom wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
2 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
3 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:DXCM stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy DexCom stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy DexCom stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Poiché eToro è una piattaforma regolamentata, dovrà completare il processo KYC, questa è una pratica standard e richiede solo un paio di minuti. Dovrà fornire un documento d'identità con foto (passaporto, patente) e una prova di indirizzo (bolletta, estratto conto bancario).
Una volta iscritto e verificato il suo conto, dovrà depositare dei fondi. eToro accetta carte di credito/debito, trasferimenti bancari e anche portafogli elettronici. Quindi qualunque sia la sua preferenza ci sarà qualcosa per lei.
Now that you’ve funded your eToro account, just type “NASDAQ:DXCM stocks" nella barra di ricerca nella parte superiore dello schermo e prema "trade".
All that’s left is to buy some NASDAQ:DXCM stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:DXCM is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy DexCom stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
DexCom is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for DexCom.
DexCom will be holding an earnings conference call on Thursday, February 11th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
DexCom, Inc. (NASDAQ:DXCM) released its quarterly earnings results on Tuesday, October, 27th. The medical device company reported $0.94 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.30. The medical device company earned $500.90 million during the quarter, compared to analysts’ expectations of $477.22 million. DexCom had a net margin of 12.69% and a trailing twelve-month return on equity of 27.29%.
View DexCom’s earnings history.
DexCom’s stock was trading at $252.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DXCM stock has increased by 62.4% and is now trading at $409.99.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:DXCM stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Oltre 95% dei fondi dei clienti sono tenuti offline, in depositi freddi, il che è fondamentale per qualsiasi broker che gestisce i suoi beni. Indipendentemente da quanto sia sicura una piattaforma, raccomandiamo di usare 2FA per aggiungere un ulteriore livello di sicurezza al suo conto.
eToro offre agli utenti una serie di caratteristiche per iniziare ad investire il più rapidamente possibile. Hanno una caratteristica relativamente unica chiamata copy trading, che le permette di guadagnare un reddito passivo facendo da specchio a trader esperti, questo le permette di iniziare a guadagnare rapidamente e le dà una migliore comprensione delle strategie usate dai professionisti. Inoltre, eToro permette agli utenti di investire in portafogli gestiti, un portafoglio gestito è una varietà di asset simili raggruppati insieme, che le permette di diversificare il suo conto, riducendo qualsiasi rischio potenziale. Per chi ha esperienza di trading precedente, può investire in mercati al di fuori delle azioni, dato che eToro permette agli utenti di commerciare ETF, materie prime, cripto e indici. Se già investe al di fuori dello spazio del mercato azionario questo può essere molto utile, perché le permette di gestire tutti i suoi investimenti in un solo posto.
DexCom updated its fourth quarter 2020 Pre-Market earnings guidance on Monday, January, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $567 million, compared to the consensus revenue estimate of $550.73 million.
18 equities research analysts have issued 1-year target prices for DexCom’s stock. Their forecasts range from $240.00 to $500.00. On average, they expect DexCom’s share price to reach $419.18 in the next year. This suggests a possible upside of 2.2% from the stock’s current price.
View analysts’ price targets for DexCom or view top-rated stocks among Wall Street analysts.
I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva. Il 68% dei conti degli investitori al dettaglio perdono denaro quando scambiano CFD con questo fornitore. Deve considerare se capisce come funzionano i CFD e se può permettersi di correre l'alto rischio di perdere i suoi soldi.
DexCom saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 3,490,000 shares, an increase of 19.9% from the December 15th total of 2,910,000 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is currently 3.1 days.
View DexCom’s Short Interest.
DexCom’s management team includes the following people:
Mr. Kevin R. Sayer, Exec. Chairman, CEO & Pres (Age 63, Pay $2.09M)
Mr. Quentin S. Blackford, CFO & COO (Age 42, Pay $1.17M)
Mr. Steven R. Pacelli, Exec. VP of Strategy & Corp. Devel. (Age 49, Pay $873.62k)
Mr. Andrew K. Balo, Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel. (Age 73, Pay $875.97k)
Mr. Jereme Sylvain, Sr. VP of Fin., Chief Accounting Officer & Corp. Controller (Age 41)
Mr. Jacob Steven Leach, Exec. VP & CTO (Age 43)
Mr. Sean Christensen, Sr. Investor Relations Mang.
Mr. Patrick Michael Murphy, Exec. VP & Chief Legal Officer (Age 42)
Chad Patterson, Sr. VP of Global Marketing
Ms. Sadie M. Stern, Exec. VP & Chief HR Officer (Age 46)
347 employees have rated DexCom CEO Kevin Sayer on Glassdoor.com. Kevin Sayer has an approval rating of 88% among DexCom’s employees.
Some companies that are related to DexCom include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
View all of DXCM’s competitors.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
Based on aggregate information from Reportlab watchlists, some companies that other DexCom investors own include NVIDIA (NVDA), PayPal (PYPL), Alibaba Group (BABA), Netflix (NFLX), Tesla (TSLA), salesforce.com (CRM), ServiceNow (NOW), The Walt Disney (DIS), The Trade Desk (TTD) and Shopify (SHOP).
DexCom trades on the NASDAQ under the ticker symbol “DXCM.”
DexCom’s stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Jennison Associates LLC (2.07%), Sumitomo Mitsui Trust Holdings Inc. (0.46%), Swiss National Bank (0.38%), Victory Capital Management Inc. (0.28%), Frontier Capital Management Co. LLC (0.24%) and California Public Employees Retirement System (0.23%). Company insiders that own DexCom stock include Andrew K Balo, Barbara Kahn, Bridgette P Heller, Donald Abbey, Heather S Ace, Jacob Steven Leach, Jeffrey Moy, Jereme M Sylvain, Kevin R Sayer, Mark G Foletta, Nicholas Augustinos, Patrick Michael Murphy, Quentin S Blackford, Richard Alexander Collins, Richard Doubleday, Shelly Ramasamy Selvaraj, Steven R Altman and Steven Robert Pacelli.
View institutional ownership trends for DexCom.
DXCM stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Sumitomo Mitsui Trust Holdings Inc., Robeco Institutional Asset Management B.V., First Trust Advisors LP, Catalyst Capital Advisors LLC, Daiwa Securities Group Inc., Janney Montgomery Scott LLC, and Aperio Group LLC. Company insiders that have sold DexCom company stock in the last year include Andrew K Balo, Barbara Kahn, Bridgette P Heller, Donald Abbey, Heather S Ace, Jacob Steven Leach, Jeffrey Moy, Jereme M Sylvain, Kevin R Sayer, Mark G Foletta, Nicholas Augustinos, Patrick Michael Murphy, Quentin S Blackford, Richard Alexander Collins, Richard Doubleday, Shelly Ramasamy Selvaraj, Steven R Altman, and Steven Robert Pacelli.
View insider buying and selling activity for DexCom or view top insider-selling stocks.
DXCM stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Strs Ohio, C WorldWide Group Holding A S, Scout Investments Inc., Fisher Asset Management LLC, Russell Investments Group Ltd., Assenagon Asset Management S.A., and Peregrine Capital Management LLC.
View insider buying and selling activity for DexCom or or view top insider-buying stocks.
Shares of DXCM can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Recensione di Interactive Brokers, Recensione di eToro, Recensione di DEGiro, Recensione di AvaTrade, Recensione di IG Markets, Rassegna dei mercati IC, Recensione di CMC Markets, Recensione di Admiral Markets e molti altri. Legga una delle recensioni per scoprire tutto sul broker e inizi a comprare azioni ora.
A Reportlab.org vogliamo assicurarci che lei abbia tutte le informazioni più rilevanti su acquisto di azioni. Le portiamo le migliori guide sul mercato azionario con recensioni personali, informazioni di base, recensioni di piattaforme, how to's e altro. Vuole ottenere altre informazioni? Allora dia un'occhiata al Azioni OTC, Azioni del NASDAQ, Azioni del NYSE, Azioni LON, Scorte FRA, Azioni ETR, Scorte dell'EPA, Azioni del TSX o Azioni Amex. Cercando informazioni più dettagliate come 5g stock, azioni biotecnologiche, azioni d'oro e altre informazioni dal nostro reportlab.
How can you buy DexCom stock on the internet?
You can easily buy DexCom stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Un'altra opzione è usare un broker regolamentato come Mercati IC o Brokers interattivi. You can an account with these brokers and start buying or trading NASDAQ:DXCM stocks in a safe and complete environment to trade in.
Where to buy DexCom stock?
You will first want to find a licensed broker that supports NASDAQ:DXCM stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:DXCM stocks in a safe and complete environment.
Is NASDAQ:DXCM stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:DXCM stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is DexCom stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:DXCM is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in DexCom stock.
How do you trade DexCom stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for DexCom stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:DXCM stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell DexCom stock?
To sell your NASDAQ:DXCM stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best DexCom stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:DXCM stock.
Stephen conosce molto bene i prodotti finanziari e in particolare ha una grande passione per i mercati azionari e i suoi partecipanti. Speriamo che le informazioni fornite le siano utili. C'è qualcosa di poco chiaro? Lasci le sue domande o commenti in fondo alla pagina.
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ |
Notiziario
Notizie recenti
| |
Il nostro punteggio |
0% commissione |
Dati in tempo reale su azioni e criptovalute
Notifiche, Consigli e Notizie
Le migliori guide su azioni e criptovalute
Recensioni su broker e scambi online
Reportlab Finanza è un sito web puramente informativo e non implica in nessun caso consigli di investimento. Tutti gli investimenti comportano rischi e lei può perdere tutti i suoi investimenti. Non investa denaro che non può permettersi di perdere.
Reportlab Finanza
38 Holburn Lane
Heckfield Green
IP21 0UB
Regno Unito
Copyright © 2022 Reportlab.Finance | Tutti i diritti riservati.
